Medtronic plc (MDT) operating KPIs

MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24

Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value

$96.54−0.57 (-0.59%)

Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%

Medtronic fDA MAUDE Reports — Patient Injury

Quarterly figures from Medtronic's filings and investor materials

Quarterly Annual Monthly

Latest, Q1 FY27

15,921

Period ended Jul 31, 2026

Change on a year earlier

+15.8%

13,754 in Q1 FY26

History

51 quarters

Since Q3 FY14

Sources

U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

Period	Ended	FDA MAUDE Reports — Patient Injury	Year on year	Source
Q1 FY27	Jul 31, 2026	15,921	+15.8%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY26	Apr 30, 2026	17,949	+68.8%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY26	Jan 31, 2026	15,254	+35.4%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY26	Oct 31, 2025	17,491	+60.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY26	Jul 31, 2025	13,754	+14.4%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY25	Apr 30, 2025	10,636	-2.8%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY25	Jan 31, 2025	11,263	-2.1%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY25	Oct 31, 2024	10,886	-16.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY25	Jul 31, 2024	12,020	+3.8%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY24	Apr 30, 2024	10,943	-10.1%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY24	Jan 31, 2024	11,510	+0.3%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY24	Oct 31, 2023	13,064	+33.4%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY24	Jul 31, 2023	11,575	+11.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY23	Apr 30, 2023	12,174	+22.2%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY23	Jan 31, 2023	11,477	+17.8%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY23	Oct 31, 2022	9,792	-2.0%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY23	Jul 31, 2022	10,360	+4.0%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY22	Apr 30, 2022	9,959	-5.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY22	Jan 31, 2022	9,745	-6.6%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY22	Oct 31, 2021	9,987	-11.6%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY22	Jul 31, 2021	9,966	-8.4%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY21	Apr 30, 2021	10,558	-17.1%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY21	Jan 31, 2021	10,437	-19.4%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY21	Oct 31, 2020	11,295	-20.2%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY21	Jul 31, 2020	10,874	-23.8%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY20	Apr 30, 2020	12,731	-17.9%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY20	Jan 31, 2020	12,946	-11.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY20	Oct 31, 2019	14,151	-21.0%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY20	Jul 31, 2019	14,278	-31.1%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY19	Apr 30, 2019	15,509	+4.3%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY19	Jan 31, 2019	14,669	+4.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY19	Oct 31, 2018	17,905	+13.3%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY19	Jul 31, 2018	20,730	+53.6%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY18	Apr 30, 2018	14,866	+6.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY18	Jan 31, 2018	14,011	-1.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY18	Oct 31, 2017	15,804	+7.0%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY18	Jul 31, 2017	13,498	-14.8%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY17	Apr 30, 2017	13,931	-40.2%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY17	Jan 31, 2017	14,247	+20.2%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY17	Oct 31, 2016	14,770	+6.1%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY17	Jul 31, 2016	15,849	+26.1%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY16	Apr 30, 2016	23,283	+83.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY16	Jan 31, 2016	11,848	-13.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY16	Oct 31, 2015	13,915	+12.6%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY16	Jul 31, 2015	12,572	+78.0%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY15	Apr 30, 2015	12,673	+68.1%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY15	Jan 31, 2015	13,731	+713.4%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY15	Oct 31, 2014	12,362	–	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY15	Jul 31, 2014	7,062	–	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY14	Apr 30, 2014	7,540	–	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY14	Jan 31, 2014	1,688	–	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗

Cite this data

StockData. (2026). Medtronic FDA MAUDE Reports — Patient Injury, quarterly Q3 FY14–Q1 FY27 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/ext-fda-maude-inj

See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.